【摘要】：目的:觀察楊梅素對人卵巢癌SKOV3細(xì)胞的生長抑制及凋亡誘導(dǎo)作用,并探討其可能機(jī)制。方法:體外培養(yǎng)人卵巢癌SKOV3細(xì)胞,按楊梅素給藥濃度將細(xì)胞分為對照組和低、中、高濃度楊梅素組,楊梅素給藥濃度分別為0、20、40和60mg·L-1。MTT法檢測各組SKOV3細(xì)胞存活率;激光共聚焦顯微鏡觀察各組SKOV3細(xì)胞核形態(tài)變化并計(jì)算異常細(xì)胞核比率;免疫熒光法檢測各組SKOV3細(xì)胞中凋亡相關(guān)蛋白-活化半胱氨酸蛋白酶3(active Caspase-3)的表達(dá);Western blotting法檢測各組SKOV3細(xì)胞中DNA損傷相關(guān)蛋白γ-H2AX的表達(dá)水平。結(jié)果:與對照組比較,低、中和高濃度楊梅素組SKOV3細(xì)胞存活率明顯下降(t=-12.35,t=-11.42,t=-10.21,P0.05);激光共聚焦顯微鏡下各濃度楊梅素組細(xì)胞出現(xiàn)核皺縮等凋亡形態(tài)學(xué)改變,且細(xì)胞中異常細(xì)胞核比率高于對照組(t=6.87,t=9.35,t=7.22,P0.05),高濃度楊梅素組異常細(xì)胞核比率高于低、中濃度楊梅素組(t=9.55,t=7.25,P0.05);隨著楊梅素給藥濃度的增加,SKOV3細(xì)胞中active Caspase-3的表達(dá)水平有升高趨勢,各濃度楊梅素組SKOV3細(xì)胞中γ-H2AX的表達(dá)水平高于對照組(t=5.41,t=3.21,t=6.58,P0.05)。結(jié)論:楊梅素可抑制人卵巢癌SKOV3細(xì)胞增殖并誘導(dǎo)其凋亡,DNA雙鏈斷裂可能是其促凋亡的機(jī)制之一。
[Abstract]:Aim: to investigate the effect of myricetin on the growth inhibition and apoptosis induction of human ovarian cancer SKOV3 cells and its possible mechanism. Methods: human ovarian cancer SKOV3 cells were cultured in vitro. The cells were divided into two groups according to the concentration of myricetin: control group and low concentration group. The survival rate of SKOV3 cells was detected by 60mg L-1.MTT method. The morphologic changes of SKOV3 nuclei were observed by laser confocal microscope and the abnormal nuclear ratio was calculated. The expression of apoptosis-related protein-activated cysteine protease 3 (active Caspase-3) in SKOV3 cells was detected by immunofluorescence assay. The expression of DNA damage associated protein 緯 -H2AX in SKOV3 cells was detected by; Western blotting method. Results: compared with the control group, the survival rate of SKOV3 cells in the myricetin group was significantly lower than that in the control group (P 0.05), and the apoptotic morphologic changes such as nuclear shrinkage were observed in the myricetin group with laser confocal microscope, and the survival rate of the cells in the myricetin group was significantly lower than that in the control group (P 0.05). The percentage of abnormal nuclei in the cells was higher than that in the control group (t = 6.87), and the ratio of abnormal nuclei in the high concentration group was higher than that in the control group (P 0.05). The expression of active Caspase-3 in SKOV3 cells showed a tendency to increase with the increase of the administration concentration of myricetin, and the ratio of abnormal nuclei in the medium concentration group was higher than that in the control group. The expression level of 緯-H2AX in SKOV3 cells of myricetin group was higher than that in control group. Conclusion: myricetin can inhibit the proliferation and induce apoptosis of human ovarian cancer SKOV3 cells, and DNA double strand break may be one of its mechanisms.
【作者單位】： 吉林醫(yī)藥學(xué)院基礎(chǔ)醫(yī)學(xué)院實(shí)驗(yàn)中心;吉林醫(yī)藥學(xué)院檢驗(yàn)學(xué)院;吉林大學(xué)基礎(chǔ)醫(yī)學(xué)院病理生理學(xué)系;吉林省吉林中西醫(yī)結(jié)合醫(yī)院體檢中心;吉林醫(yī)藥學(xué)院臨床醫(yī)學(xué)院;
【基金】：國家自然科學(xué)基金面上項(xiàng)目資助課題(81372793) 吉林省教育廳十二五科技項(xiàng)目資助課題(2013361) 吉林省大學(xué)生創(chuàng)新創(chuàng)業(yè)項(xiàng)目資助課題(20141027)
【分類號(hào)】：R737.31

【參考文獻(xiàn)】

相關(guān)期刊論文 前6條

1 劉燕妮;童文聰;龐會(huì)芳;練娟娟;;宮頸癌的流行情況調(diào)查與診療[J];當(dāng)代醫(yī)學(xué);2011年12期

2 林國鋇;謝燕;李國文;;楊梅素的研究進(jìn)展[J];國際藥學(xué)研究雜志;2012年06期

3 梁馨予;張婷;周永;施琳穎;陳軍麗;王麗;康超;朱俊東;糜漫天;;楊梅素減輕高糖誘導(dǎo)的血管內(nèi)皮細(xì)胞氧化應(yīng)激損傷[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2013年21期

4 郭海清;任鋒;陳亞利;張向穎;段鐘平;孫華;張晶;;楊梅素對HepG2細(xì)胞凋亡的影響[J];北京醫(yī)學(xué);2014年09期

5 李留霞;李冰熠;李秀芳;張?zhí)m蘭;王凱娟;張建營;;上皮性卵巢癌組織中IMP1的表達(dá)[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2014年03期

6 楊香麗;黃冬梅;孫欣欣;;卵巢癌術(shù)后2種治療方案療效分析[J];鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2014年04期

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李萍;彭莉;;順鉑聯(lián)合5-氟尿嘧啶在晚期宮頸癌治療中的臨床療效[J];當(dāng)代醫(yī)學(xué);2011年19期

2 趙政敏;徐滕滕;;宮頸癌患者圍手術(shù)期舒適護(hù)理中的臨床效果[J];中國醫(yī)藥科學(xué);2013年09期

3 劉同方;于華忠;陳雁梅;高夢;鄭紅巖;劉建蘭;;楊梅素植物來源及提取分離方法研究進(jìn)展[J];安徽農(nóng)業(yè)科學(xué);2014年15期

4 郭海清;任鋒;陳亞利;張向穎;段鐘平;孫華;張晶;;楊梅素對HepG2細(xì)胞凋亡的影響[J];北京醫(yī)學(xué);2014年09期

5 湯凱雯;陳歷排;杜佩妍;吳蘊(yùn)瑜;;化療聯(lián)合順鉑腹腔熱灌注治療中晚期卵巢癌術(shù)后的效果[J];廣東醫(yī)學(xué);2015年11期

6 王敏;;順鉑聯(lián)合5-Fu治療晚期宮頸癌近期療效觀察[J];醫(yī)藥論壇雜志;2013年07期

7 劉濤;龍本文;羅歡;金吉芬;解璞;彭志軍;;荸薺楊梅的揮發(fā)油成分分析[J];化學(xué)試劑;2014年09期

8 王石秀;況榮華;傅穎s，

本文編號(hào)：2280520